Medtronic plc (NYSE: MDT) received an upgrade from Stifel Financial Corp, which raised its price target for the company following a positive assessment of the HUGO...
AstraZeneca has announced significant progress in the development of a new blood pressure therapy, achieving its primary endpoint in a Phase 3 clinical trial. This breakthrough...